標普和納斯達克內在價值 聯繫我們

Bristol-Myers Squibb Company PFD CONV 2 BMYMP OTC

Other OTC • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score
45/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) 是一家上市公司 屬於 醫療保健 板塊,經營於 制药 - 綜合 產業. 公司總部位於 Princeton, DE, 美国. 現任CEO為 Christopher S. Boerner.

BMYMP 擁有 IPO日期為 2003-12-08, 34,100 名全職員工, 在 Other OTC.

關於 Bristol-Myers Squibb Company PFD CONV 2

Bristol-Myers Squibb is a global pharmaceutical company that discovers, develops, and markets innovative drugs across multiple therapeutic areas, including cardiovascular disease, cancer, and immune disorders. The company has established itself as a leader in immuno-oncology, a rapidly growing field combining immunotherapy with cancer treatment. With approximately 70% of its revenue generated from the United States market, Bristol-Myers Squibb demonstrates a significant concentration in the U.S. compared to many of its industry peers, reflecting its strong presence in the world's largest pharmaceutical market.

公司詳情
所屬板塊醫療保健
細分行業制药 - 綜合
國家美国
交易所Other OTC
貨幣USD
IPO日期2003-12-08
首席執行官Christopher S. Boerner
員工數34,100
交易資訊
當前價格$400.00
52週區間400-1050
Beta0.27
ETF
ADR
聯繫我們
🎓
SharesGrow 學院
學習如何計算內在價值,發現被低估的股票。
每週線上課程
給我們留言